FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News

Hope for UV-induced eye diseases

Augenheilkunde, Cornea Lab Experimentelle Augenheilkunde

Special contact lenses protects stem cells from UV-damage/harm

Scientists of the Dept. of Ophthalmology, University Hospital Cologne, and DFG Research Unit 2240 demonstrated that commercially available UV-blocking contact lenses are able to protect limbal stem cells in the eye from UV-damage. The team around Dr. Maria Notara, Univ. – Prof. Dr. Claus Cursiefen of the ophthalmology center of the University Hospital Cologne and Univ.-Prof. Dr. Bjoern Schumacher, director of the Institute for Genome Stability in Ageing and Disease at the CECAD research center showed that UV-induced DNA damage in stem cells can be prevented while the cells retain their function and characteristics.

These results open the way to a new prophylactic treatment for patients who are affected by UV-related eye conditions or the ones receiving ocular stem cell transplantation. The results of the research have been recently published at the “Scientific Reports” a Journal of the Nature Publishing Group.

The research was sponsored by a Johnson and Johson IIS Study grant, the EU Horizon 2020 Arrest Blindness Program and the DFG Research Unit 2240.

Related posts

February 25, 2021

Eye clinic to win two renowned awards in the beginning of 2021


Read more
Zoom Meeting Shanghai

(v. l. n r.) Prof. Dr. med. Cursiefen, PD Dr. rer. nat. Felix Bock, Prof. Dr. med. Bi Yanglong Bi (top center)?), Prof. Dr. med. Takahiko Hayashi, PD Dr. med. Mario Matthaei

December 17, 2020

2nd Shanghai-Cologne Ophthalmic Research Meeting


Read more
November 6, 2020

FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program


Read more

News

  • Eye clinic to win two renowned awards in the beginning of 2021
  • German Ophthalmological Society (DOG) – Professor Dr. Claus Cursiefen elected as Secretary General
  • 2nd Shanghai-Cologne Ophthalmic Research Meeting
  • Antonia Howaldt accepted into the Cologne Clinician Scientist Program
  • FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck